Information  X 
Enter a valid email address

InnovaDerma PLC (IDP)

  Print   

Thursday 12 March, 2020

InnovaDerma PLC

Director/PDMR Shareholding

RNS Number : 9735F
InnovaDerma PLC
12 March 2020
 

  LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Company")

 Director/PDMR shareholding

 

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, announces that it was notified today, that Joseph Bayer, Executive Chairman of the Company, has purchased 12,000 Ordinary Shares of €0.10 each in the Company at a price of 46.7 pence per Ordinary Share (the "Acquisition") which will be held via his Australian Superannuation Fund which Mr Bayer controls.  He now holds 141,000 Ordinary Shares in the Company via his Australian Superannuation Fund. 

Following the Acquisition, Joseph Bayer has, through direct and indirect holdings, a total interest in the Company of 190,240 Ordinary Shares representing approximately 1.34% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

 

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

[email protected]

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Joseph Bayer

2. 

Reason for the Notification

 

a)

Position/status

Executive Chairman

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP   GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume - 1 2,000 Ordinary Shares

Price - 46.7 pence per Ordinary Share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

12 March 2020

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUUOSRRSUOAAR

a d v e r t i s e m e n t